“My facility is concerned with the CP3R data regarding a breast cancer patient receiving Chemotherapy + Herceptin now being coded as a single agent. Have you addressed this with the Commission on Cancer?”

As many of us are preparing for and completing our 1st quarter Cancer Committee meetings, RQRS and CP3R data will likely be presented for review and discussion. One particular measure, MAC for Breast, stands out due to the drug category coding change of  coding chemotherapy agent Herceptin as Biologic therapy/Immunotherapy.  Effective with cases diagnosed 1/1/20113 , patients who receive 1 chemotherapy agent + Herceptin will be…

Posted on Mar. 6, 2015 in From Our Perspective

Consultant Spotlight: Stacy Elliott-Torrez, CTR

Stacy Elliott

Stacy has worked with Registry Partners Incorporated  in both part-time and full-time capacities since 2007.  She has worked on a variety of projects consisting of state report only, state central registry and accredited cancer program projects.  She is a project manager working with CTR teams on numerous projects in addition to serving as a quality manager.   Prior to her experience with RPI she worked at Goldston Regional Hospital…

Posted on Mar. 5, 2015 in Spotlight